Tourmaline Bio Inc.
Biotechnology
Healthcare
TRML
25.69 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
47.77
52 week high
47.75
high
47.79
52 week low
0.00
low
47.72
growth
107.34 %
previous Close
47.75
P/E ratio
market cap
575 M
div yield
0
net incoming
-23.09 M
-0.53 %
net profit margin
-2309200000.00 %
0.00 %
operating incoming
-25.97 M
0.98 %
net change in cash
-3.91 M
-180.99 %
cash on hand
31.42 M
-11.06 %
top